Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease

Neurology

Volumn 66, Issue 10, 2006, Pages 1517-1522

  Peters, N ^a   Holtmannspotter M ^a   Opherk, C ^a   Gschwendtner, A ^a   Herzog, J ^a   Samann P ^b   Dichgans, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEINE; FIBRINOGEN;

ADULT; AGE; ARTICLE; BARTHEL INDEX; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRAIN ATROPHY; BRAIN ISCHEMIA; BRAIN SIZE; CADASIL; COGNITION; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATTIS DEMENTIA RATING SCALE; MULTIINFARCT DEMENTIA; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RATING SCALE; RISK FACTOR; SCORING SYSTEM; STROKE; STRUCTURED INTERVIEW FOR THE DIAGNOSIS OF ALZHEIMER DEMENTIA AND MULTI INFARCT DEMENTIA SCORE; SYSTOLIC BLOOD PRESSURE; ATROPHY; BLOOD; BRAIN; COGNITIVE DEFECT; COMORBIDITY; HYPERCHOLESTEROLEMIA; HYPERTENSION; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PSYCHOLOGICAL ASPECT; SMOKING;

ADULT; ATROPHY; BRAIN; CADASIL; COGNITION DISORDERS; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; RISK FACTORS; SMOKING;

EID: 33745365423     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000216271.96364.50     Document Type: Article

References (34)

1. Du AT, Schuff N, Chao LL, et al. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging 2005; Epub ahead of print.
2. Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-1635.
3. Mungas D, Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001;57:2229-2235.
4. Mungas D, Reed BR, Jagust WJ, et al. MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002;59:867-873.
5. Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-939.
6. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710.
7. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 CADASIL patients. Brain 2004;127:2533-2539.
8. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psych 2005;162:2078-2085.
9. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-489.
10. Sormani MP, Rovaris M, Valsasina P, Wolinsky JS, Comi G, Filippi M. Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis. Neurology 2004;62:1432-1434.
11. Enzinger C, Fazekas F, Matthews PM, et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005;64:1704-1711.
12. Enzinger C, Ropele S, Smith S, et al. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. Ann Neurol 2004;55:563-569.
13. Filippi M, Rovaris M, Inglese M, et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1489-1496.
14. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke 2004;35:1603-1608.
15. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688.
16. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997;244:266-270.
17. Strassburger TL, Lee HC, Daly EM, et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke 1997;28:1410-1417.
18. Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA, O'Brien JT. Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology 2004;63:1892-1897.
19. den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003;126:170-175.
20. Sachdev PS, Valenzuela M, Wang XL, Looi JC, Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 2002;58:1539-1541.
21. Fox NC, Schott JM. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet 2004;363:392-394.
22. Liu RS, Lemieux L, Bell GS, et al. A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage 2003;20:22-33.
23. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003;60:989-994.
24. Molko N, Pappata S, Mangin JF, et al. Diffusion tensor imaging study of subcortical gray matter in CADASIL. Stroke 2001;32:2049-2054.
25. Ruchoux MM, Maurage CA. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997;56:947-964.
26. Chan D, Janssen JC, Whitwell JL, et al. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 2003;362:1121-1122.
27. van den Boom R, Lesnik Oberstein SA, Ferrari MD, Haan J, Van Buchem MA. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages - 3rd-6th decades. Radiology 2003;229:683-690.
28. DeCarli C, Miller BL, Swan GE, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke 1999;30:529-536.
29. Holtmannspoetter M, Peters N, Opherk C, et al. Diffusion MR histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005;36:2559-2565.
30. Mungas M, Harvey D, Reed B, et al. Longitudinal Volumetric MRI change and rate of cognitive decline. Neurology 2005;65:565-571.
31. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989;8:431-440.
32. O'Sullivan M, Singhal S, Charlton R, Markus HS. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004;62:702-707.
33. Duning T, Kloska S, Steinstrater O, Kugel H, Heindel W, Knecht S. Dehydration confounds the assessment of brain atrophy. Neurology 2005;64:548-550.
34. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676-1695.